Home
SITE Cohort Study
MUST Research Group

Uveitis

UveitisUveitisUveitis
Home
SITE Cohort Study
MUST Research Group
More
  • Home
  • SITE Cohort Study
  • MUST Research Group

Uveitis

UveitisUveitisUveitis
  • Home
  • SITE Cohort Study
  • MUST Research Group

SITE Cohort Study

The SITE Cohort Study has contributed 17 papers out of 96 (17.7%) identified by the American Uveitis Society as the top ~10 papers of the year for resident ophthalmologist training purposes each year since inception in 2009 through end as of 2017, more than any other study. Its findings have been presented and discussed at 40+ peer-reviewed scientific meetings around the world.


The SITE Cohort Study has also received 17 awards for its many accomplishments. 

PEER-REVIEWED PUBLICATIONS

The following journal articles may be downloaded for free.
Ocular Inflammation in Behçet's Disease: Incidence of Ocular ComplicationsLong-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammationAzathioprine for ocular inflammatory diseasesMethotrexate for ocular inflammatory diseasesOverall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugsOcular disease in patients with ANCA-positive vasculitisCyclophosphamide for ocular inflammatory diseasesHypopyon in patients with uveitisCyclosporine for ocular inflammatory diseasesMycophenolate mofetil for ocular inflammationAdverse effects of smoking on patients with ocular inflammationAppropriate use and reporting of uncontrolled case series in the medical literatureRisk of relapse in primary acute anterior uveitisHigh-dose intravenous corticosteroids for ocular inflammatory diseasesRisk of corticosteroid-induced hyperglycemia requiring medical therapy among patients with inflammatory eye diseasesRisk of hypotony in noninfectious uveitisRisk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritisPeripapillary choroidal neovascularization in pars planitisMarginal structural models for comparing alternative treatment strategies in ophthalmology using observational dataResponse of pediatric uveitis to tumor necrosis factor-α inhibitorsRisk of choroidal neovascularization among the uveitidesIncidence of visual improvement in uveitis cases with visual impairment caused by macular edemaFactors predictive of remission of new-onset anterior uveitis
Periocular corticosteroid injections in uveitis: effects and complicationsUveitis Reactivation in Children Treated With Tumor Necrosis Factor Alpha InhibitorsThe Risk of Intraocular Pressure Elevation in Pediatric Noninfectious UveitisRisk of Retinal Neovascularization in Cases of UveitisRemission of Intermediate Uveitis: Incidence and Predictive FactorsAdalimumab for Ocular InflammationRisk of Ocular Hypertension in Adults with Noninfectious UveitisComparison Between Methotrexate and Mycophenolate Mofetil Monotherapy for the Control of Noninfectious Ocular Inflammatory DiseasesVisual Acuity Outcome over Time in Non-Infectious UveitisFactors Predictive of Remission of Chronic Anterior UveitisExudative Retinal Detachment in Ocular Inflammatory Diseases: Risk and Predictive FactorsRisk of Cataract in Intermediate UveitisCorneal Endothelial Transplantation in Uveitis: Incidence and Risk FactorsIncidence of and Risk Factors for Cataract in Anterior UveitisUse of Immunosuppression and the Risk of Subsequent Overall or Cancer MortalityUse of immunosuppression and subsequent cancer incidence

Copyright © 2025 Uveitis - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept